VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Ascendo Biotechnology, Inc.

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 25 out of 100

  • Biotech & therapeutics
Business model
B2B
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Ascendo Biotechnology is a Phase 1 clinical-stage company developing first-in-class innate immune-checkpoint therapies for cancer and autoimmune disease. Its lead candidate, ASD141, is an anti-CD11b antibody designed to activate innate immunity in tumors resistant to PD-1/PD-L1 therapy.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy